Neo-Synephrinol



Indications and Reactions:

Role Indications Reactions
Primary
Mydriasis 50.0%
Drug Use For Unknown Indication 16.7%
General Anaesthesia 16.7%
Product Used For Unknown Indication 16.7%
Drug Dependence 25.0%
Eye Irritation 25.0%
Heart Sounds Abnormal 25.0%
Infantile Apnoeic Attack 25.0%
Secondary
Drug Use For Unknown Indication 28.0%
Product Used For Unknown Indication 13.3%
Induction Of Anaesthesia 10.7%
Tocolysis 10.7%
Infection Prophylaxis 5.3%
Premedication 5.3%
Anaesthesia 2.7%
Analgesic Therapy 2.7%
Aortic Valve Disease 2.7%
Coronary Artery Bypass 2.7%
Diabetes Mellitus 2.7%
General Anaesthesia 2.7%
Hypotension 2.7%
Maintenance Of Anaesthesia 2.7%
Mydriasis 2.7%
Choroidal Neovascularisation 1.3%
Macular Degeneration 1.3%
Intra-uterine Death 16.7%
Nephrogenic Diabetes Insipidus 16.7%
Tachycardia 16.7%
Anhedonia 8.3%
Erythema Multiforme 8.3%
Fear 8.3%
Hypercapnia 8.3%
Oxygen Saturation Immeasurable 8.3%
Ventricular Tachycardia 8.3%
Concomitant
Product Used For Unknown Indication 61.2%
Drug Use For Unknown Indication 21.5%
Coronary Artery Bypass 4.8%
Mitral Valve Replacement 1.9%
Aortic Valve Replacement 1.8%
Intra-aortic Balloon Placement 1.5%
Preoperative Care 0.8%
Hypertension 0.7%
Deep Vein Thrombosis 0.6%
Atrial Fibrillation 0.6%
Cardiac Operation 0.6%
Cardiopulmonary Bypass 0.6%
Catheterisation Cardiac 0.5%
Pain 0.5%
Anticoagulant Therapy 0.4%
Anxiety 0.4%
Diabetes Mellitus 0.4%
Chronic Obstructive Pulmonary Disease 0.4%
Aortic Dissection 0.3%
Blood Pressure Management 0.3%
Pain 14.1%
Anhedonia 12.8%
Injury 11.5%
Unevaluable Event 8.3%
Vomiting 6.4%
Emotional Distress 5.8%
Renal Failure 5.8%
Anxiety 5.1%
Fear 4.5%
Depression 3.2%
Renal Impairment 3.2%
Renal Injury 2.6%
Urinary Tract Infection 2.6%
Weight Increased 2.6%
Corneal Oedema 1.9%
Death 1.9%
Multi-organ Failure 1.9%
Renal Failure Acute 1.9%
Respiratory Failure 1.9%
Septic Shock 1.9%